Pets At Home Group Plc (LON:PETS) Rating Reaffirmed
Liberum Capital reconfirmed their “Buy” rating on Pets At Home Group Plc (LON:PETS) in a recent report issued to clients on 30 November.
From a total of 4 analysts covering Pets At Home Group Plc (LON:PETS) stock, 4 rate it a ”Buy”, 0 a “Sell”, and 0 a ”Hold”. This means that 100% of the ratings are positive. The highest target price is GBX 360 while the lowest target price is GBX 325. The mean of all analyst targets is GBX 345 with a 31.00% above today’s (GBX 263.35) stock price. Pets At Home Group Plc was the topic of 21 analyst reports since July 27, 2015 according to the firm StockzIntelligence Inc. Liberum Capital maintained shares on November 30 with “Buy” rating. Liberum Capital maintained shares with “Buy” rating and GBX 350 target share price in a report from a November 23. Berenberg maintained PETS stock in a recent report from October 2 with “Buy” rating.
The stock increased 0.13% or GBX 0.35 on November 27, striking GBX 263.35. Approximately shares of stock traded hands. Pets at Home Group PLC (LON:PETS) has declined 0.64% since May 1, 2015 and is downtrending. It has outperformed by 0.25% the S&P500.
Pets at Home Group Plc is a United Kingdom firm engaged in the sale of pet services and products, and accessories through retail outlets and Websites. The company has a market cap of 1.31 billion GBP. The principal activity of the Company is that of a specialist retailer of pet food, pet related products and pet accessories. It has 19.23 P/E ratio. The Firm offers pet food, such as advanced nutrition, grocery food, treats and other food.
According to Zacks Investment Research, “Petmed Express is America’s largest pet pharmacy, delivering prescription and non-prescription pet medications and health and nutritional supplements for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet.” Get a free copy of the Zacks research report on Pets at Home Group PLC (PETS)